Evidium Secures $22M Series A to Advance Transparent Healthcare AI Platform
核心洞察
Evidium (搜索) closed a $22 million Series A funding round co-led by Health2047 (搜索) and WGG Partners (搜索) to scale its computational medical knowledge platform.
The company's AI platform transforms clinical knowledge into transparent, traceable models that enable healthcare leaders to better understand patient journeys and predict clinical outcomes.
Funding will accelerate product development, expand clinical modeling capabilities, and support strategic hiring across AI research, clinical science, and business development.
Healthcare AI company Evidium (搜索) has secured $22 million in Series A funding to advance its platform that transforms medical knowledge into computational models with transparent reasoning capabilities. The round was co-led by Health2047 (搜索), the venture studio of the American Medical Association, and WGG Partners (搜索), with participation from Interwoven Ventures (搜索) and Mindset Ventures (搜索).
The San Francisco-based company is addressing a critical challenge in healthcare where medical knowledge remains fragmented across text, statistics, and isolated systems. Evidium (搜索)'s platform creates computational models that can be validated, traced, and applied across both care delivery and insurance environments.
"Healthcare runs on knowledge, but until now, much of that knowledge has been locked in text, statistics, and silos," said Carl Bate, founder and CEO of Evidium (搜索). "We're solving this challenge by making medical knowledge computational and AI more reliable. We enable healthcare leaders to see opportunities for improvement more clearly, reason more precisely, and share timely insights."
Platform Capabilities and Applications
Evidium (搜索)'s platform offers multiple precision products built on a shared, scalable foundation. The company currently provides quality insights for clinicians and care teams, as well as probabilistic forecasting for medical risk-bearing organizations including insurers, health plans, and integrated delivery networks.
The platform's clinical and cost modeling capabilities allow stakeholders to better understand each condition and the associated care journey and cost. Unlike traditional AI systems, Evidium (搜索)'s approach prioritizes clinical accuracy and provides experts with traceable reasoning they can review, validate, and use.
"Our customers are provided with non-black-box insights in support of their work - every prediction and insight is fully traceable back to the clinical evidence and logic that produced it," Bate explained. "In turn, enabling faster learning cycles and knowledge diffusion. Our products augment existing tools including generative AI with clinically grounded, fully transparent logic."
Strategic Expansion Plans
The funding will accelerate product development and expand Evidium (搜索)'s clinical modeling capabilities while scaling go-to-market operations. The company plans strategic hires across AI research engineering, clinical science, and business development to meet growing demand from health plans and provider organizations.
"Building on our strong quality insights and performance record with health systems, we are now harnessing Evidium (搜索)'s platform with insurers and others across the risk spectrum," said Rajiv Sood, General Manager of Insurance and Risk at Evidium.
The company's roadmap includes further product development for clinicians, health plans and other risk takers, and life sciences organizations. This expansion reflects the platform's ability to serve multiple stakeholder needs while maintaining knowledge integrity.
Industry Impact and Vision
The investment advances Evidium (搜索)'s mission to scale medical knowledge by bringing precision and transparency to clinical intelligence. The platform enables experts to better understand patient journeys, predict clinical trajectories and costs, and promote better outcomes through shared, accessible insights.
"Healthcare's future depends on systems that can learn, explain, and enhance the role of physicians," said Lawrence K. Cohen, CEO of Health2047 (搜索). "Evidium (搜索) is advancing that kind of system—one where knowledge isn't trapped in charts or claims data but continuously refined through use."
Herb Madan of WGG Partners (搜索) emphasized the platform's significance for high-stakes healthcare decisions: "Evidium (搜索)'s substrate powers how AI systems reason in high-stakes domains - delivering a new class of reliable and precision insights healthcare leaders can act on."
The company's "precision first" approach addresses healthcare's fundamental need for knowledge integrity, where the accessibility and accuracy of medical information directly impacts patient outcomes and costs. By making insights shareable and transparent, Evidium (搜索) aims to reduce silos and misalignments in service of more effective and affordable healthcare delivery.